Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder.

Coccaro EF, Lee RJ, Kavoussi RJ.

J Clin Psychiatry. 2009 Apr 21;70(5):653-62. doi: 10.4088/JCP.08m04150.

PMID:
19389333
2.

Impulsive aggressive behavior: open-label treatment with citalopram.

Reist C, Nakamura K, Sagart E, Sokolski KN, Fujimoto KA.

J Clin Psychiatry. 2003 Jan;64(1):81-5.

PMID:
12590628
3.

Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers.

Lee R, Kavoussi RJ, Coccaro EF.

Int Clin Psychopharmacol. 2008 Nov;23(6):337-41. doi: 10.1097/YIC.0b013e32830fbdd2.

PMID:
18854722
4.

Fluoxetine and impulsive aggressive behavior in personality-disordered subjects.

Coccaro EF, Kavoussi RJ.

Arch Gen Psychiatry. 1997 Dec;54(12):1081-8.

PMID:
9400343
5.

Serotonin function and antiaggressive response to fluoxetine: a pilot study.

Coccaro EF, Kavoussi RJ, Hauger RL.

Biol Psychiatry. 1997 Oct 1;42(7):546-52.

PMID:
9376450
6.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
7.

Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder.

Coccaro EF, Lee R, Breen EC, Irwin MR.

Psychiatry Res. 2015 Oct 30;229(3):844-9. doi: 10.1016/j.psychres.2015.07.078. Epub 2015 Jul 29.

8.

Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.

Kavoussi RJ, Coccaro EF.

J Clin Psychiatry. 1998 Dec;59(12):676-80.

PMID:
9921702
9.

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.

Hale A, Corral RM, Mencacci C, Ruiz JS, Severo CA, Gentil V.

Int Clin Psychopharmacol. 2010 Nov;25(6):305-14. doi: 10.1097/YIC.0b013e32833a86aa.

PMID:
20856123
10.

Fluoxetine versus placebo in posttraumatic stress disorder.

Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.

J Clin Psychiatry. 2002 Mar;63(3):199-206.

PMID:
11926718
11.

Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.

Sheehan DV, Nemeroff CB, Thase ME, Entsuah R; EPIC 016 Study Group.

Int Clin Psychopharmacol. 2009 Mar;24(2):61-86. doi: 10.1097/YIC.0b013e32831980f2.

PMID:
19238088
12.

Personality predictors of antiaggressive response to fluoxetine: inverse association with neuroticism and harm avoidance.

Phan KL, Lee R, Coccaro EF.

Int Clin Psychopharmacol. 2011 Sep;26(5):278-83. doi: 10.1097/YIC.0b013e32834978ac.

PMID:
21795983
13.

Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder.

Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Vielma W, Montes C, Pumarino L, Roa N.

Actas Esp Psiquiatr. 2007 Nov-Dec;35(6):387-92.

PMID:
17597424
14.

Intermittent explosive disorder: development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.

Coccaro EF.

Compr Psychiatry. 2011 Mar-Apr;52(2):119-25. doi: 10.1016/j.comppsych.2010.05.006. Epub 2010 Jul 8.

PMID:
21295216
15.

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA.

J Clin Psychiatry. 2002 Mar;63(3):225-31.

PMID:
11926722
16.

Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder.

Coccaro EF, Lee R, Kavoussi RJ.

J Psychiatr Res. 2010 Feb;44(3):137-42. doi: 10.1016/j.jpsychires.2009.07.004. Epub 2009 Sep 19.

PMID:
19767013
17.
18.
19.

Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder.

Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Jiménez M, Galleguillos F, Bustamante ML.

Psychiatr Genet. 2010 Feb;20(1):25-30. doi: 10.1097/YPG.0b013e328335125d.

PMID:
20010449
20.

Supplemental Content

Support Center